PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-313.81%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would suspect a firm-specific problem if peers maintain profit growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
289.12%
SBC growth of 289.12% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or staff additions causing more equity grants.
-122.10%
Working capital is shrinking yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage if sales remain robust.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
113.90%
AP growth of 113.90% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or credit policies affecting the difference.
-180.39%
Other WC usage shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage if top-line is stable or growing.
2618.61%
Growth of 2618.61% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or one-off revaluations explaining the difference.
17.02%
CFO growth of 17.02% while Healthcare median is zero at 0.00%. Walter Schloss would see a small edge that may compound with consistent execution.
-23.76%
CapEx declines yoy while Healthcare median is 0.00%. Seth Klarman would note a short-term FCF advantage if revenue is stable.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-23.76%
Reduced investing yoy while Healthcare median is 0.00%. Seth Klarman sees potential advantage in near-term liquidity if revenue remains stable.
-278.89%
Debt repayment yoy declines while Healthcare median is 0.00%. Seth Klarman fears increased leverage if expansions do not yield quick returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.